Psilocybin mushrooms have become the subject of increasing interest from researchers around the world. Scientific studies indicate potential therapeutic benefits associated with psilocybin, the main active ingredient in these so-called magic mushrooms. At the same time, misuse and unsupervised use of strains such as Golden Teacher carry serious risks, which requires special caution, medical consultation and respect for applicable law.
Benefits of psilocybin in mental health treatment
Research from recent years suggests that psilocybin contained in psilocybin mushrooms may support mental health when administered in a controlled, clinical setting. Studies explore its potential in the treatment of depression, end-of-life anxiety, post-traumatic stress disorder (PTSD), and addictions such as smoking. In many publications, the most promising results are associated with treatment-resistant depression, where psilocybin is discussed as a potential breakthrough in modern psychiatry – always under strict medical supervision.
One of the key scientific hubs in this field is the Psychedelic Research Centre at Imperial College London. Researchers there not only look at depression, but also investigate the role of psilocybin in conditions such as anorexia and other eating disorders. This opens completely new perspectives on how psychedelic-assisted psychotherapy might support people whose symptoms have not responded to standard treatment.
Quality of psilocybin experience vs. therapeutic benefits
A key element of the potential benefits associated with psilocybin (including that found in Golden Teacher) is not only the dose, but also the quality of the overall experience. Scientific reports emphasize that so-called “mystical-type experiences,” emotional openness and deep emotional breakthroughs can correlate with improvements in mood and reduced symptoms of depression or anxiety.
This is why modern psilocybin research focuses not just on the substance itself, but on the entire therapeutic process: preparation, expectations, therapeutic support, integration sessions and a safe environment. Without these elements, the same dose of psilocybin mushroom can lead to a chaotic, overwhelming experience instead of a potentially healing one.
Note: improper use of Golden Teacher psilocybin mushrooms
It is extremely important to emphasize that any potential benefits associated with psilocybin mushrooms are only observed in properly supervised, clinical or research settings. Using them on your own, outside a medical framework, without a guide and in an inappropriate mental state can lead to intense fear, panic, mental decompensation and other health risks.
Research clearly indicates that the environment (“set & setting”) in which psilocybin mushrooms such as Golden Teacher are consumed has a crucial impact on the experience. A safe, supervised environment with professional psychological support increases the chance of a structured, therapeutic process. Uncontrolled use in noisy, unsafe, or emotionally unstable circumstances significantly raises the risk of a so-called “bad trip” and long-term mental distress.
Guide (tripsitter) and safety during the experience
Introducing a guide (tripsitter) or therapist when working with psilocybin mushrooms is considered one of the basic safety principles in psychedelic-assisted psychotherapy, and we describe this topic more broadly in our article on set & setting. The person guiding the session provides emotional support, helps navigate difficult content and reduces the risk of uncontrolled behaviour. This is especially important for people who are encountering psilocybin or other psychedelics for the first time.
In clinical research, the role of a guide is usually played by an experienced psychologist, psychiatrist or psychotherapist trained in psychedelic work. Recreational use of psilocybin without such support and without prior medical assessment significantly increases the risk of adverse reactions and should be avoided.
The dangers of Golden Teacher and other psilocybin mushrooms
Despite the growing number of studies on therapeutic use, psilocybin mushrooms such as Golden Teacher still carry real risks. Inadequate dosage, lack of preparation, ignoring contraindications or mixing psychedelics with other substances can lead to serious consequences for mental and physical health.
Although psilocybin and LSD are ranked relatively low on some drug-harm scales, experts recommend using psilocybin or ketamine only in professional clinical settings. The risk of fatal overdose may be low and the risk of classical addiction is considered small, but this does not mean that psychedelic substances are “safe” for everyone. For people with mental instability or a family history of certain disorders, even a single experience can have a very heavy impact.
Side effects and health risks
Consumption of psilocybin mushrooms can cause short-term side effects such as nausea, dizziness, confusion, pupil dilation, increased heart rate and disorientation in time and space. These symptoms are often temporary, but during an intense trip they can be very unpleasant and frightening.
Psilocybin mushrooms have gained broader public attention because of research into their possible health-promoting properties, which is also reflected in expert publications such as studies in leading medical journals. Legal changes in places like Oregon or Colorado, and discussion of psilocybin therapy, have made many people reach for psychedelics not only in therapeutic contexts, but also purely for recreational use. And this carries a whole spectrum of risks – especially without medical screening and psychological support.
Long-term symptoms and vulnerable groups
For some people – particularly those with a predisposition to mental illness – psychedelic experiences may trigger psychotic or manic episodes, or exacerbate existing disorders. So far, we cannot unequivocally prove the long-term safety of psilocybin for all groups of patients.
One study involving 1,000 participants did not show a direct correlation between initiating psychosis and psychedelic consumption. However, in many clinical trials, people with a personal or family history of serious mental illness are systematically excluded – especially those with schizophrenia or bipolar affective disorder. It is assumed that such conditions may be activated (though not necessarily) during a psychedelic experience.
Research on the harmfulness of psychedelics
One study conducted in a group of people diagnosed with bipolar affective disorder found that one-third of respondents reported worsening symptoms after using psychedelics, and about 3% required medical intervention. It is important to note that these were not tightly controlled clinical trials – most participants used psychedelics recreationally, in uncontrolled settings.
Summarising this line of research, we quote Dr. Bryan Roth of the University of North Carolina: “Anyone suffering from a serious mental disorder – such as schizophrenia or bipolar affective disorder – should not take psychedelics.”
Legal risks
In many countries, possession, cultivation and consumption of psilocybin mushrooms is illegal. Legal consequences (fines, criminal records, imprisonment) are a serious risk that must be taken into account before anyone even considers using these substances. Law is changing dynamically in some regions, but in most jurisdictions psilocybin remains a controlled substance.
In Poland, owning a growkit (mycelium for research or collection purposes) is allowed, but allowing it to fruit into psilocybin-producing mushrooms is not. By triggering mushroom growth, you expose yourself to criminal liability. Remember that the products in our store are intended for mycological and educational purposes only – not for cultivation of psilocybin mushrooms in countries where it is prohibited.
The content on the psychodelicroom.pl website is educational, research-based, and expresses many opinions that should be treated with caution. We advise against using any substances that affect consciousness, as all of these substances can both heal and be very harmful. In particular, we advise against cultivating mushrooms from growkits in countries where it is illegal – including Poland – because it involves criminal liability. We recommend that you dispose of the growkits purchased from us within 72 hours of receiving them.
Sources:
https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.22010073
https://www.nytimes.com/2023/02/10/well/mind/psychedelics-therapy-ketamine-mushrooms-risks.html
https://podyplomie.pl/psychiatria/38177,zagrozenia-i-nadzieje-w-leczeniu-depresji-psylocybina
Log in with Facebook
Log in with Google